• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eventide Healthcare & Life Sciences Fund

+ Add to Watchlist

ETNHX:US

15.75 USD 0.50 3.08%

As of 19:59:59 ET on 07/31/2014.

Snapshot for Eventide Healthcare & Life Sciences Fund (ETNHX)

Year To Date: -3.08% 3-Month: +0.83% 3-Year: - 52-Week Range: 13.80 - 19.91
1-Month: -10.15% 1-Year: +12.42% 5-Year: - Beta vs SPX: -

Mutual Fund Chart for ETNHX

No chart data available.
  • ETNHX:US 15.75
  • 1M
  • 1Y
Interactive ETNHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ETNHX

Eventide Healthcare & Life Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund will invest at least 80% of its net assets in equity and equity-related securities of companies in the healthcare and life sciences industries.

Inception Date: 12-27-2012 Telephone: 1-866-447-4228
Managers: FINNY GEORGE KURUVILLA
Web Site: www.catalystmutualfunds.com

Fundamentals for ETNHX

NAV (on 2014-07-31) 15.75
Assets (M) (on 2014-07-31) 105.88
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for ETNHX

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ETNHX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 1.00
12b1 Fee 0.20
Expense Ratio 1.63

Top Fund Holdings for ETNHX

Filing Date: 06/30/2014
Name Position Value % of Total
Agios Pharmaceuticals Inc 94,698 4,339,041 3.670%
Medivation Inc 41,568 3,204,033 2.710%
Bluebird Bio Inc 76,940 2,967,573 2.510%
Dyax Corp 302,964 2,908,458 2.460%
AtriCure Inc 152,451 2,802,051 2.370%
GW Pharmaceuticals PLC 25,015 2,683,821 2.270%
Salix Pharmaceuticals Ltd 21,758 2,683,821 2.270%
Veracyte Inc 154,693 2,648,352 2.240%
AbbVie Inc 46,923 2,648,352 2.240%
Supernus Pharmaceuticals Inc 240,779 2,636,529 2.230%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil